Trupanion, Inc. (NASDAQ:TRUP) COO John R. Gallagher Sells 3,100 Shares of Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John R. Gallagher sold 3,100 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total value of $102,269.00. Following the sale, the chief operating officer now owns 25,549 shares in the company, valued at approximately $842,861.51. The trade was a 10.82 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Trupanion Price Performance

Shares of Trupanion stock opened at $33.20 on Wednesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The business’s 50 day simple moving average is $43.50 and its two-hundred day simple moving average is $47.33. The stock has a market capitalization of $1.41 billion, a P/E ratio of -144.35, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. Analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on TRUP shares. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Piper Sandler reduced their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

Institutional Investors Weigh In On Trupanion

Several institutional investors and hedge funds have recently made changes to their positions in TRUP. FMR LLC lifted its position in Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after purchasing an additional 1,170,202 shares during the period. Balyasny Asset Management L.P. lifted its position in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after purchasing an additional 661,559 shares during the period. BNP Paribas Financial Markets lifted its position in Trupanion by 170.7% during the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock valued at $16,248,000 after purchasing an additional 212,545 shares during the period. Freestone Grove Partners LP bought a new position in Trupanion during the fourth quarter valued at approximately $7,776,000. Finally, Baillie Gifford & Co. lifted its position in Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock valued at $33,806,000 after purchasing an additional 147,341 shares during the period.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.